Lipid-based slow-release formulation of amikacin sulfate reduces foreign body-associated infections in mice.

Treatment and prophylaxis of uncomplicated infections with standard systemic antibiotics are usually successful. However, standard systemic antibiotic therapy alone is frequently unsatisfactory in certain circumstances, such as the presence of a foreign body (FB), necrotic tissue, overwhelming bacte...

Descrición completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Principais autores:	Roehrborn, A A, Hansbrough, J F, Gualdoni, B, Kim, S
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Microbiology (ASM) 1995
Assuntos:	Research Article
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162821/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7486914/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.8.1752
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!